即时比分500网电脑版

金博棋牌苹果版本

Home/Investors/ Press Releases

金博棋牌苹果版本

  • Company Information
  • Financial Information
  • Stock Data
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
    • 9Aug

    CymaBay Reports Second Quarter 2018 Financial Results and Provides Corporate Update金博棋牌苹果版本

    2Aug

    CymaBay to Report Second Quarter 2018 Financial Results on Thursday, August 9金博棋牌苹果版本

    25Jun

    CymaBay Therapeutics Added to the Russell 3000® and Russell 2000® Indexes金博棋牌苹果版本

    19Jun

    CymaBay Therapeutics to Host Analyst and Investor Day on June 26, 2018金博棋牌苹果版本

    8May

    CymaBay Reports First Quarter 2018 Financial Results and Provides Corporate Update金博棋牌苹果版本

    8May

    CymaBay Therapeutics Announces the Initiation of a Phase 2b Study of Seladelpar in Patients with Non-Alcoholic Steatohepatitis金博棋牌苹果版本

    1May

    CymaBay to Report First Quarter 2018 Financial Results on Tuesday, May 8金博棋牌苹果版本

    11Apr

    CymaBay Announces Positive New 12-Week and 26-Week Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis at The International Liver Congress™ 2018金博棋牌苹果版本

    15Mar

    CymaBay Reports Fourth Quarter and Fiscal 2017 Financial Results and Provides Corporate Update金博棋牌苹果版本

    6Mar

    CymaBay to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15金博棋牌苹果版本

    RSS
    Show All

    金博棋牌苹果版本

    • 7575 Gateway Blvd., Suite 110
      Newark, CA 94560
    • +1 (510) 293-8800
    • +1 (510) 293-9090

    金博棋牌苹果版本

    金博棋牌苹果版本

    即时比分500网捷报比分手机版篮球金彩网福彩3d字谜汇总江苏快三下载官方网站加拿大大发28预测大白江苏五分是正规彩票